Project Grant R21DE032151
- The National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121), awarded a $913,000 Project Grant to the University of Southern California to support research on periodontal regeneration using supramolecular nanomaterials. The project aims to identify biologically active peptides, specifically the leucine-rich amelogenin peptide (LRAP), that can stimulate the differentiation of periodontal ligament cells...
- This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $443,576 to the University of Washington to develop bioengineered 3D tooth germs for tooth regeneration research. The key objectives are to: 1) investigate how biomaterial composition and mechanical properties regulate stem cell renewal and support long-term growth of odontogenic epithelial stem cells and neural...
- This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $557,606.00 to fund a research project titled "Cellular and Molecular Control of Periodontal Tissue Regeneration" at Harvard Medical School. The award aims to advance fundamental knowledge about periodontal stem cells and mechanisms for natural periodontal tissue regeneration, with a focus on the periodontal...
- This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), is for the development of REGENDOGEL (RG), a new class of dental material that stimulates both dental pulp and dentin regeneration. The $1,196,355 award to Regendodent, Inc. will compare the original RG formulation using bovine-derived dentin matrix molecules (DMMs) with a new formulation using porcine-derived DMMs. The project...
- The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $685,594 Project Grant under the Oral Diseases and Disorders Research (CFDA 93.121) program to The Pennsylvania State University (Penn State) to support research on leveraging microsurgery and bioprinting to enable rapidly vascularized tissue engineering for craniomaxillofacial (CMF) injury reconstruction. The project aims to advance a novel microsurgical "vascular micropuncture" technique to enhance the...
- The National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121), awarded a $870,334 Project Grant to The Research Foundation For The State University Of New York (RF SUNY) for the project "DEVELOPMENT OF AN EARLY TOOTH ORGANOID VIA HUMAN INDUCED PLURIPOTENT STEM CELLS". The goal of this 2-year project is to develop an in vitro system using human induced pluripotent stem cells (iPSCs) to better...
- This federal Project Grant award of $588,952 from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), is funding research to develop a bio-inspired scaffold (PerióPatch) for regenerating Sharpey's fibers and the periodontal ligament (PDL). The research aims to integrate biophysical and biochemical cues into a matrix to guide PDL stem cell migration, growth, and the formation of well-aligned PDL principal and...
- This $408,375 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research (CFDA 93.121) program, supports the development of a novel "Biomimetic Nitric Oxide and Hydroxyapatite Duo" for advanced direct pulp capping. The key products and services to be delivered through this 2-year award include: Characterization of the physical-mechanical properties of a Hydroxyapatite-fortified Peptide Amphiphile (PA-HA)...
- This Project Grant award, funded by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), supports the co-development of autologous oral mucosal grafts for therapeutic purposes. The $1,240,877 award to Cedars-Sinai Medical Center aims to engineer vascularized, functional oral tissue grafts that can be tailored to diverse clinical needs, leveraging advances in single cell/spatial multiomics, developmental...
- This $476,287 federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will fund research to investigate the role of the MERTK receptor tyrosine kinase in promoting alveolar bone regeneration after tooth extraction. The primary objectives are to determine the effects of MERTK signaling on resident alveolar bone stem cells and the recruitment and phenotype of immune cells in the...
PERSONALIZED BIOPRINTING TECHNOLOGY FOR DE NOVO PDL REGENERATION - ABSTRACT AVULSION OF PERMANENT TEETH IS ONE OF THE MOST SERIOUS DENTAL INJURIES. THE PERIODONTAL LIGAMENT (PDL) IS DAMAGED AND CONTAMINATED DURING AVULSION AND THE OUTCOME AFTER REPLANTATION OF THE AVULSED TEETH IS POOR. CELL-BASED THERAPY USING PDL STEM CELLS (PDLSCS) PROVIDES US WITH THE OPPORTUNITY TO REGENERATE THE PDL OF AVULSED TEETH. RECENT LARGE ANIMAL STUDIES HAVE SHOWN PROMISE OF CELL-BASED THERAPIES FOR MANAGING AVULSED TEETH. HOWEVER, THERE IS A LACK OF SYSTEMATIC DESIGN AND DEPLOYMENT OF THE TYPE OF CUTTING-EDGE TISSUE ENGINEERING TECHNOLOGY THAT WOULD ULTIMATELY LEAD TO DEVELOPMENT OF A PERSONALIZED MEDICINE APPROACH FOR THE DE NOVO PDL REGENERATION OF AVULSED TEETH. HERE WE PROPOSE TO INCORPORATE A NEWLY DEVELOPED, TWO-STEP TECHNOLOGY, NAMELY THE USE OF BIOSYNSPHERES AND PERSONALIZED 3D-BIOPRINTING FOR STEM CELL- MEDIATED PDL REGENERATION. THE FIRST STEP INVOLVES THE PRODUCTION OF BIO-INK CONTAINING PDLSCS ENCAPSULATED IN MICROSPHERES, TERMED PDLSC-BIOSYNSPHERES. THE SECOND STEP EMPLOYS A CUSTOM-MADE 3D-BIOPRINTER DESIGNED WITH SPECIFIC ALGORITHMS THAT CAN PRINT A LAYER OF PDLSC- BIOSYNSPHERES ONTO THE DECONTAMINATED AND DENUDED TOOTH ROOT FOLLOWING ITS NATURAL SURFACE TOPOGRAPHY, WITH A DESIRED AND UNIFORMED THICKNESS FOR PDL REGENERATION ON THE ENTIRE ROOT SURFACE. WE HYPOTHESIZE THAT THE LOST PDL ON AVULSED TEETH CAN BE REGENERATED DE NOVO USING PERSONALIZED BIOPRINTING WITH PDLSC-BIOSYNSPHERES. IN AIM 1, WE WILL OPTIMIZE THE GENERATION OF PDLSC-BIOSYNSPHERES AND CHARACTERIZE THEIR BIOLOGICAL BEHAVIORS AFTER BEING PRINTED ONTO THE ROOT SURFACE IN VITRO AND WITH AN ESTABLISHED SCID MOUSE MODEL IN VIVO. IN AIM 2, WE WILL UTILIZE A SIMPLE MINI-SWINE MODEL TO CHARACTERIZE THE REGENERATION OF FUNCTIONAL PDL IN VIVO. WE ANTICIPATE THAT THE COMBINATION OF PDLSC-BIOSYNSPHERES AND PERSONALIZED 3D-BIOPRINTING TECHNOLOGY WILL RESULT IN CONSISTENT PDL REGENERATION ON THE ROOT, WHICH WILL GENERATE PRELIMINARY DATA THAT SETS THE STAGE FOR MORE EXTENSIVE LARGE ANIMAL STUDIES IN A FUTURE R01 APPLICATION. THE SIGNIFICANT CLINICAL IMPACT IS THE POTENTIAL TO ESTABLISH A DENTAL TRAUMA MANAGEMENT CENTER AT THE TENNESSEE INSTITUTE OF REGENERATIVE MEDICINE (TENNIRM) FOR REPLANTING AVULSED TEETH AIMING AT SUCCESSFUL LONG-TERM FAVORABLE OUTCOMES. FUTURE ENDEAVOR WILL INCLUDE ESTABLISHING STEM CELL BANKING TO FACILITATE AND SECURE THE CELL SOURCE FOR SUCH MEDICAL THERAPIES.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 9/22/25 | ||
| Not listed | $423.5k | 8/9/23 |